APP and Alzheimer disease: Notably, LoNA expression was elevated in the hippocampus of APP/PS1 mice, accompanied by reduced levels of rRNAs, and knockdown of LoNA restored rRNA expression and rescued cognitive and memory impairments in the same AD mouse model [29].